Shotgun metagenomics data from faecal samples of 47 patients with mild cognitive impairment: Insights from the memoir study

List of Authors

  1. Marina Mora-Ortiz ,  
  2. Fernando Abollo-Jiménez
    ,  
  3. Esther Porras-Pérez ,  
  4. José Lopez-Miranda
    ,  
  5. Antonio Camargo
    ,  
  6. Pablo Perez-Martinez
Article Authors & roles Authors Peer review record Peer review Metrics
Cite

Abstract

This Data Note describes the MEMOIR dataset, consisting of shotgun metagenomics data from faecal samples of 47 individuals over the age of 65 diagnosed with mild cognitive impairment (MCI). The dataset was generated to investigate the relationship between gut microbiota functionality and cognitive impairment through the gut-brain-microbiota axis. The dataset includes sequencing data that can be used to explore gut microbiota gene profiles linked to MCI. The dataset was generated using high-throughput shotgun metagenomics technology to identify microbial genes and their potential involvement in cognitive health. This allows for functional interrogation of the gut microbial community and its impact on MCI progression, providing a rich resource for future research. The dataset supports analyses aimed at understanding how dietary interventions (Mediterranean diet and WHO diet) and probiotic treatments influence MCI progression, as well as the potential sex-based differences in response to these interventions. The MEMOIR dataset adheres to the FAIR principles and is intended to facilitate reproducibility and data reuse in studies exploring the gut microbiota’s role in cognitive decline. No conclusions or analyses are presented in this note, but the dataset offers potential for novel insights into personalised treatment strategies for MCI in ageing populations. Future publications from the MEMOIR project will explore the results from these analyses in detail, contributing to a better understanding of the role of gut microbiota in cognitive decline and identifying potential microbial targets for intervention.

ClinicalTrials.gov, identifier NCT05029765, registration date of 2021-09-01. For further details, please refer to: https://clinicaltrials.gov/study/NCT05029765?term=NCT05029765&rank=1

Plain Language Summary

This Data Note presents the MEMOIR dataset, which contains data from faecal samples of 47 people over the age of 65 who have mild cognitive impairment (MCI). MCI is a disorder that impacts memory and cognitive abilities and has the potential to progress to dementia. The data collected aims to investigate the relationship between gut bacteria (gut microbiota) and their influence on cognitive health, mediated by the gut-brain-microbiota axis. Through the application of cutting-edge DNA sequencing techniques, the dataset offers comprehensive insights into the genetic profiles of gut bacteria that may contribute to cognitive decline. This information is crucial for researchers examining the role of gut microbiota in conditions such as MCI. Additionally, the dataset facilitates exploration of the effects of dietary patterns, specifically the Mediterranean diet and the World Health Organization (WHO) recommended diet, along with probiotic interventions, on MCI, including potential gender-based differences in treatment response.

The MEMOIR dataset follows high standards to make sure it is easy to use and share, and no conclusions are drawn from the data in this report. However, this data will support future studies that aim to find new ways to prevent or treat MCI by targeting the gut microbiota. Upcoming publications from the MEMOIR project will explore these findings in more detail, helping us better understand how the gut bacteria might play a role in cognitive decline and how we can develop treatments to slow or reverse it.

Corresponding author
Marina Mora-Ortiz
0000-0002-6662-2932
Grant information

This project has received funding from the European Union’s Horizon 2020 research and innovation program under Marie Skłodowska-Curie grant agreement No 847468 -IMIBIC Fellowship Programme for Personalised and Precision Medicine (P2Med) Project "PI16/01777" was funded by Instituto de Salud Carlos III and co-funded by European Union (ERDF, "A way to make Europe"). Projects "PI19/00299" & "PI22/00925", funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. Project PI-0055-2021 funded by Junta de Andalucía-Consejería de Salud y Consumo. PPM is the recipient of the PI16/01777 funding. PI19/00299 and PI22/00925 were funded to AC. PI-0055-2021 was funded to MM-O and AC. MMO is recipient of the MCA project 847468.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright
© 2025 Marina Mora-Ortiz (Corresponding Author, Co-Author); Fernando Abollo-Jiménez (Co-Author); Esther Porras-Pérez (Co-Author); José Lopez-Miranda (Co-Author); Antonio Camargo (Co-Author); Pablo Perez-Martinez (Co-Author) Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

First version published
Latest version published

Comments

Authors & roles

Marina Mora-Ortiz

Department of Internal Medicine, Lipids and Atherosclerosis Unit, University Hospital Reina Sofia, Córdoba, Andalusia, 14004, Spain

Department of Medical and Surgical Sciences, Universidad de Cordoba Facultad de Medicina y Enfermeria, Córdoba, Andalucía, 14004, Spain

GC-09, Nutrigenomics and Metabolic Syndrome, Maimonides Biomedical Research Institute of Cordoba, Córdoba, Andalucía, 14004, Spain

Roles
Corresponding Author, Co-Author, Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Investigation, Methodology, Resources, Visualization, Writing – Original Draft Preparation
0000-0002-6662-2932

Fernando Abollo-Jiménez

Unidad de Bioinformática y Bioestadística, Maimonides Biomedical Research Institute of Cordoba, Córdoba, Andalucía, 14004, Spain

Roles
Co-Author, Data Curation, Formal Analysis, Investigation, Methodology, Software

Esther Porras-Pérez

Department of Internal Medicine, Lipids and Atherosclerosis Unit, University Hospital Reina Sofia, Córdoba, Andalusia, 14004, Spain

Department of Medical and Surgical Sciences, Universidad de Cordoba Facultad de Medicina y Enfermeria, Córdoba, Andalucía, 14004, Spain

GC-09, Nutrigenomics and Metabolic Syndrome, Maimonides Biomedical Research Institute of Cordoba, Córdoba, Andalucía, 14004, Spain

Roles
Co-Author, Investigation, Methodology, Project Administration, Writing – Review & Editing
0000-0003-3281-8838

José Lopez-Miranda

Department of Internal Medicine, Lipids and Atherosclerosis Unit, University Hospital Reina Sofia, Córdoba, Andalusia, 14004, Spain

Department of Medical and Surgical Sciences, Universidad de Cordoba Facultad de Medicina y Enfermeria, Córdoba, Andalucía, 14004, Spain

GC-09, Nutrigenomics and Metabolic Syndrome, Maimonides Biomedical Research Institute of Cordoba, Córdoba, Andalucía, 14004, Spain

Health Institute Carlos III, CIBER Pathophysiology of obesity and nutrition (CIBEROBN), Córdoba, Andalucía, 14004, Spain

Roles
Co-Author, Conceptualization, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Writing – Review & Editing

Antonio Camargo

Department of Internal Medicine, Lipids and Atherosclerosis Unit, University Hospital Reina Sofia, Córdoba, Andalusia, 14004, Spain

Department of Medical and Surgical Sciences, Universidad de Cordoba Facultad de Medicina y Enfermeria, Córdoba, Andalucía, 14004, Spain

GC-09, Nutrigenomics and Metabolic Syndrome, Maimonides Biomedical Research Institute of Cordoba, Córdoba, Andalucía, 14004, Spain

Health Institute Carlos III, CIBER Pathophysiology of obesity and nutrition (CIBEROBN), Córdoba, Andalucía, 14004, Spain

Roles
Co-Author, Conceptualization, Data Curation, Funding Acquisition, Investigation, Project Administration, Resources, Supervision, Writing – Review & Editing

Pablo Perez-Martinez

Department of Internal Medicine, Lipids and Atherosclerosis Unit, University Hospital Reina Sofia, Córdoba, Andalusia, 14004, Spain

Department of Medical and Surgical Sciences, Universidad de Cordoba Facultad de Medicina y Enfermeria, Córdoba, Andalucía, 14004, Spain

GC-09, Nutrigenomics and Metabolic Syndrome, Maimonides Biomedical Research Institute of Cordoba, Córdoba, Andalucía, 14004, Spain

Health Institute Carlos III, CIBER Pathophysiology of obesity and nutrition (CIBEROBN), Córdoba, Andalucía, 14004, Spain

Roles
Co-Author, Conceptualization, Funding Acquisition, Investigation, Project Administration, Resources, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing

Awaiting peer review

Downloads over the last 12 months:

Cited by

via Crossref

View citing articles